Basics Gossamer Bio, Inc. IPO Date: February 4, 2019 Sector: Healthcare Industry: Biotech Market Cap: $498.96M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 3.58% Avg Daily Range (30 D): $0.11 | 3.89% Avg Daily Range (90 D): $0.09 | 4.02% Institutional Daily Volume Avg Daily Volume: 1.18M Avg Daily Volume (30 D): 3.48M Avg Daily Volume (90 D): 3.06M Trade Size Avg Trade Size (Sh.): 178 Avg Trade Size (Sh.) (30 D): 226 Avg Trade Size (Sh.) (90 D): 243 Institutional Trades Total Inst.Trades: 1,272 Avg Inst. Trade: $1.48M Avg Inst. Trade (30 D): $1.86M Avg Inst. Trade (90 D): $2.75M Avg Inst. Trade Volume: .27M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.72M Avg Closing Trade (30 D): $1.59M Avg Closing Trade (90 D): $3.19M Avg Closing Volume: 330.09K     News Sep 25, 2025 @ 11:41 AM Respira Therapeutics Enters into Agreement with Go... Source: Prnewswire Sep 25, 2025 @ 11:31 AM Gossamer Bio Enters into Option Agreement to Acqui... Source: Business Wire Aug 14, 2025 @ 5:00 PM Pulmonary Hypertension associated with Interstitia... Source: Delveinsight Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight Dec 2, 2024 @ 12:30 PM XOMA Royalty Acquires Pulmokine for $20 Million Ad... Source: Globe Newswire Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.62 $-.17 $-.16 Diluted EPS $-.62 $-.17 $-.16 Revenue $ 40.24M $ 11.49M $ 9.89M Gross Profit $ $ $ Net Income / Loss $ -138.74M $ -38.27M $ -36.64M Operating Income / Loss $ -145.62M $ -38.77M $ -36.81M Cost of Revenue $ $ $ Net Cash Flow $ -60.77M $ -2.84M $ -17.16M PE Ratio